Perinatal Subarachnoid Hemorrhage
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Attenuation of cerebral vasospasm and secondary injury by 17beta-estradiol following experimental subarachnoid hemorrhage.
|
18950269 |
2009 |
Subarachnoid Hemorrhage, Spontaneous
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Attenuation of cerebral vasospasm and secondary injury by 17beta-estradiol following experimental subarachnoid hemorrhage.
|
18950269 |
2009 |
Subarachnoid Hemorrhage, Aneurysmal
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Attenuation of cerebral vasospasm and secondary injury by 17beta-estradiol following experimental subarachnoid hemorrhage.
|
18950269 |
2009 |
Subarachnoid Hemorrhage, Intracranial
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Attenuation of cerebral vasospasm and secondary injury by 17beta-estradiol following experimental subarachnoid hemorrhage.
|
18950269 |
2009 |
Hypotension
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Hypotensive effects of intravenously administered uridine and cytidine in conscious rats: involvement of adenosine receptors.
|
18313046 |
2008 |
Prenatal Exposure Delayed Effects
|
0.300 |
Biomarker
|
disease |
CTD_human |
Perinatal caffeine, acting on maternal adenosine A(1) receptors, causes long-lasting behavioral changes in mouse offspring.
|
19092996 |
2008 |
Bradycardia
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Hypotensive effects of intravenously administered uridine and cytidine in conscious rats: involvement of adenosine receptors.
|
18313046 |
2008 |
Substance Withdrawal Syndrome
|
0.300 |
Biomarker
|
disease |
CTD_human |
Influence of adenosine receptor agonists on benzodiazepine withdrawal signs in mice.
|
16226742 |
2005 |
Drug Withdrawal Symptoms
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Influence of adenosine receptor agonists on benzodiazepine withdrawal signs in mice.
|
16226742 |
2005 |
Withdrawal Symptoms
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Influence of adenosine receptor agonists on benzodiazepine withdrawal signs in mice.
|
16226742 |
2005 |
Drug toxicity
|
0.300 |
Biomarker
|
group |
CTD_human |
Do adenosine receptors play a role in amitriptyline-induced cardiovascular toxicity in rats?
|
15641640 |
2004 |
Hypotension
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Do adenosine receptors play a role in amitriptyline-induced cardiovascular toxicity in rats?
|
15641640 |
2004 |
Adverse reaction to drug
|
0.300 |
Biomarker
|
group |
CTD_human |
Do adenosine receptors play a role in amitriptyline-induced cardiovascular toxicity in rats?
|
15641640 |
2004 |
Ventricular Dysfunction
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Do adenosine receptors play a role in amitriptyline-induced cardiovascular toxicity in rats?
|
15641640 |
2004 |
Myocardial Infarction
|
0.300 |
Therapeutic
|
disease |
CTD_human |
Role of adenosine in delayed preconditioning of myocardium.
|
12160945 |
2002 |
Catalepsy
|
0.300 |
Therapeutic
|
disease |
CTD_human |
Effect of adenosine receptor agonists and antagonists on morphine-induced catalepsy in mice.
|
9407998 |
1997 |
Waxy flexibility
|
0.300 |
Therapeutic
|
phenotype |
CTD_human |
Effect of adenosine receptor agonists and antagonists on morphine-induced catalepsy in mice.
|
9407998 |
1997 |
Sleep Apnea, Obstructive
|
0.210 |
Biomarker
|
disease |
BEFREE |
However, little is known about whether ADORA1 takes part in the course of neuronal cell injury after intermittent hypoxia exposure which was the main pathological characteristic of OSAHS.
|
29380238 |
2018 |
Sleep Apnea, Obstructive
|
0.210 |
Biomarker
|
disease |
RGD |
Sleep fragmentation impairs ventilatory long-term facilitation via adenosine A1 receptors.
|
18787037 |
2008 |
Hyperalgesia
|
0.200 |
Biomarker
|
phenotype |
RGD |
Adenosine A1 receptor agonists reduce hyperalgesia after spinal cord injury in rats.
|
20065990 |
2010 |
Ventricular Fibrillation
|
0.200 |
Biomarker
|
disease |
RGD |
[Adenosine induces ventricular arrythmias in hearts with chronic chagas cardiomyopathy].
|
20334814 |
2010 |
Diabetic Nephropathy
|
0.200 |
Biomarker
|
disease |
RGD |
Protective effect of adenosine in diabetic neuropathic pain is mediated through adenosine A1-receptors.
|
19552053 |
2009 |
Lung diseases
|
0.200 |
Biomarker
|
group |
RGD |
Ischaemic and pharmacological preconditionings protect liver via adenosine and redox status following hepatic ischaemia/reperfusion in rats.
|
18307414 |
2008 |
Ventricular Dysfunction, Left
|
0.200 |
Biomarker
|
phenotype |
RGD |
Adenosine A1 receptor expression during the transition from compensated pressure overload hypertrophy to heart failure.
|
17211253 |
2007 |
Cerebral Infarction
|
0.200 |
Biomarker
|
disease |
RGD |
Moderate cerebral venous congestion induces rapid cerebral protection via adenosine A1 receptor activation.
|
17067559 |
2006 |